FDA: Prasugrel [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-12-20 14:46 (4576 d 09:59 ago) – Posting: # 12085
Views: 31,261

Hi intuitivepharma,

❝ […] bioequivalence requirement [based on USFDA individual product bioequivalence recommendations] for Prasugrel Hydrochloride


❝ Can I justify my ANDA if test formulation is bioequivalent for the active metabolite (R-138727) and not bioequivalent for the Inactive metabolite R-95913?


Following the – nonbinding – recommendations of the guidance:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
267 visitors (0 registered, 267 guests [including 44 identified bots]).
Forum time: 01:45 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5